Analytical Method Development and Validation for Simultaneous Estimation of 5-methyl-N-{[2-(morpholin-4-yl)quinolin-3-yl]methyl}-1,3-thiazol-2-amine in Bulk Form

References

[1] Bentley, K. W. Nat; Prod. Rep.; 2005, 22, 249-268.

[2] Scott, J. D.; Williams, R. M.; Chem. Rev.; 2002, 102, 1669-1730.

[3] .Iwasa, K.; Moriyasu, M.; Yamori, T.; Turuo T.; Lee, D. U.; Wiegrebe, W. J.; Nat. Prod.; 2001, 64, 896-898.

[4] Zhang, Q.; Tu, G.; Zhao, Y.; Cheng, T.; Tetrahedron; 2002, 58, 6795-6798.

[5] Gao, M.; Kong, D.; Clearfield, A.; Zheng, Q. H.; Bioorg. Med. Chem. Lett.; 2006, 16, 2229-2233.

[6] Fodale, V.; Santamaria, L. B.; Eur. J. Anaesthesiol.; 2002, 466- 473.

[7] Shinohara, T.; Takeda, A.; Toda, J.; Terasawa, N.; Sano, T.; Heterocycles; 1997, 46, 555-565.

[8] Takada, K.; Uehara, T.; Nakao, Y.; Matsunaga, S.; Soest, R. W. M.; Fusetani, N.; J. Am. Chem. Soc.; 2004, 126, 187-193.

[9] Naoi, M.; Maruyama, W.; Sasuga, S.; Deng, Y.; Dostert, P.; Ohta, S.; Takahashi, T.; Neurochem. Int.; 1994, 25, 475- 481.

[10] Iwasa, K.; Moriyasu, M.; Tachibana, Y.; Kim, H. S.; Wataya, Y.; Wiegrebe, W.; Bastow, K. F.; Cosentino, L. M.; Kozuka, M.; Lee, K. H.; Bioorg. Med. Chem.; 2001, 9, 2871.

[11] Methods of Analysis-http://www.pharmatutor.org/pharma-analysis

[12] Douglas, A.; Skoog, F.; James, H.; Stanley, R. C. Liquid Chromatography. In Instrumental Analysis, 9th ed.; Cengage Learning India Pvt. Ltd.: New Delhi, 2007; 893 - 934.

[13] Skoog; Holler; Crouch; Liquid Chromatography. In Instrumental Analysis, Cengage Learning India. New Delhi. 2011; 893.

[14] Chatwal, R. G.; Anand, K. S. High Performance Liquid Chromatography. In Instrumental Methods of Chemical Analysis, 5th ed.; Himalaya Publishers. Mumbai, 2010; 2.570 - 2.629.

[15] Sharma, B. K. High Performance Liquid Chromatography. In Instrumental Methods Of Chemical Analysis, 24th ed.; Goel Publishers.: Meerut, 2005; 295 - 300.

[16] Alfonso, R. G.; Ara, H. D. M.; Glen, R. H.; Thomas, M.; Nicholas, G. P.; Roger, L.S.; Steve, H. W. Chromatography. In Remington: The Science and Practice of Pharmacy, 20th ed.; Lippincott Williams & Wilkins: Philadelphia, 2000; 587

[17] Madhuri R, Avinash K, Narendra D. Development of HPTLC method for simultaneous estimation of Atenolol and Nifidipine in combined dosage form. Asian Journal of chemistry. 2010; 22: 5951-5955.

[18] Raval H.V, Patel DM, Patel C.N.Estimation of Metoprolol Tartrate and Chlorthalidone in Combined Dosage Form by UV Spectrophotometric Methods.Research journal of pharmacy and technology 2011;04:1132.

[19] Bauer J, Quick J, Krogh S, Shada D.Stability-indicating assay for chlorthalidone formulation: Evaluation of the USP analysis and a high- performance liquid chromatographic analysis.Journal of Pharmaceutical Sciences 1983; 72:924-928.

[20] Brijesh Singh, Patel D K, Ghosh S K. A Reversed phase high performance chromatographic method for determination of chlorthalidone in pharmaceutical formulation. International journal of pharmacy and pharmaceutical sciences 2009; 1: 43-45.

[21] Stephen Walters M, Dalia Stonys B. Determination of Chlorthalidone and Clonidine hydrochloride in tablets by HPLC. J Chromatogr. Sci.1983; 21: 43-45.

[22] Madhu Babu K, Bikshal Babu k.Reverse Phase-HPLC Method Development and Validation for the simultaneous estimation of Azilsartan Medoxomil and Chlortalidone in Pharmaceutical Dosage Forms journal of Atoms and Molecules 2012; 2: 117–126.

[23] Mhaske R A, Garole D J, Mhaske A A, Sahasrabudhe S.RP-HPLC Method For Simultataneous Determination Of Amlodipine Besylate, Valsartan, Telmisartan, Hydrochlorothiazide And Chlorthalidone: Application To Commercially Available Drug Products. 2012;3: 141- 149.

[24] Al Azzam KM, Saad B, Aboul-Enein HY .Development and validation of a reversed-phase high-performance liquid chromatographic method for the simultaneous determination of amiloride hydrochloride, atenolol, hydrochlorothiazide, and chlorthalidone in their combined mixtures. Journal of AOAC International. 2011; 92: 404-409.

[25] Sa'sa' S I,Jalal I M, Khalil H S.Determination of Atenolol Combinations with Hydrochlorothiazide and Chlorthalidone in Tablet Formulations by Reverse-Phase HPLC. Journal of Liquid Chromatography 1988; 11: 1673-1696

[26] Nada. S. Abdelwahab.Determination of atenolol, chlorthalidone and their degradation products by TLC-densitometric and chemometric methods with application of model updating. Anal. Methods 2010; 2:1994-2001.

[27] Al Azzam KM, Abdalla A. Elbashir, Mohammed A. Elbashir, Saad B, Abdul Hamid S. Simultaneous Determination of Atenolol and Chlorthalidone in Pharmaceutical Preparations by Capillary-Zone Electrophoresis. Analytical Letters 2009; 42: 1458-1470.

[28] El-Gindy A, Sallam S, Abdel-Salam RA.HPLC method for the simultaneous determination of atenolol and chlorthalidone in human breast milk. J. Sep. Sci. 2008; 31:677-82.

[29] 515112010731500Mohamed S. Elgawish, Samia M. Mostafa , Abdalla A. Elshanawane.Simple and rapid HPLC method for simultaneous determination of atenolol and chlorthalidone in spiked human plasma. Saudi Pharmaceutical Journal 2011; 19:43–49.

[30] Claudio G, Anna T, Sergio C, Giovanni Z. Simultaneous determination of atenolol and chlorthalidone in plasma by high-performance liquid chromatography application to pharmacokinetic studies in man. J. Chrom. B: Bio.Sci. App. 1997; 698:187–194.

[31] ICH Validation of analytical procedures: Text and methodology Q2 (R1), International Conference on Harmonization, Geneva, Switzerlan

@article{1703742,
      author = {Yogita Shinde, Kalpana Patankar-Jain},
      title = {Analytical Method Development and Validation for Simultaneous Estimation of 5-methyl-N-{[2-(morpholin-4-yl)quinolin-3-yl]methyl}-1,3-thiazol-2-amine in Bulk Form},
      journal = {Iconic Research And Engineering Journals},
      year = {2022},
      volume = {6},
      number = {3},
      pages = {106-111},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1703742.pdf},
      abstract = {A reverse phase high performance liquid chromatographic technique for validating 5-methyl-N-[2-(morpholin-4-yl)quinolin-3-yl]methyl-1,3-thiazol-2-amine (MMQMTA) in its original form has been developed. A HYPERSIL (250 x 4.6 mm, 5 m) ID column was used for the chromatography, and the mobile phase was a 60:40 mixture of methanol and ammonium acetate with a flow rate of 1.0 ml/min. The detection wavelength was 235 nm. MMQMTA had a retention time of 6.812 min. The approach yields linearity responses at concentrations of 4?24 mg/ml of MMQMTA. MMQMTA has a detection limit of 0.021 g/ml and an area of 2.61. Area 6.812 and 0.05 g/ml were reported as the MMQMTA limits of quantification, and the MMQMTA recovery rate was determined to be 99.98%. The technique is helpful for ensuring and monitoring the quality of pharmaceutical and bulk formulations.},
      keywords = {5-methyl-N-{[2-(morpholin-4-yl)quinolin-3-yl]methyl}-1,3-thiazol-2-amine, MMQMTA, RP-HPLC, validation.},
      month = {September},
  }